TP53 and cervical cancer: For instance, MDM4 inhibitor NSC146109 has demonstrated potent anti-proliferative effects in cervical cancer by stabilizing p53 and enhancing its transcriptional activity, thereby promoting apoptosis and sensitizing cells to chemotherapy [27].